Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
J Exp Clin Cancer Res | 2024 Feb
October 11, 2023
Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer
Cell Rep | April 2023
February 16, 2022
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Cell | May 2015
February 16, 2022
Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening
eLife | Nov 2016
February 16, 2022
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Cell | Jan 2018
February 16, 2022
Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids
Nat Protoc | April 2021
February 16, 2022
Sequential cancer mutations in cultured human intestinal stem cells
Nature | May 2015
February 16, 2022
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
Nat Cancer | April 2022
February 16, 2022
Long-term expanding human airway organoids for disease modeling
EMBO J | February 2019
February 16, 2022
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
NPJ Precis Oncol | April 2021
